Endovion

N/A

Report date: 2024/11/23 20:00:08

NME

Base Information

Drug NameEndovion

Drug Alias NameSCO-101NS-3728GTPL-4273HY-105917CS-0026942

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionChloride channel blockersBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitorsSRSF protein kinase 1 inhibitors

TargetsChloride channelBroad substrate specificity ATP-binding cassette transporter ABCG2SRSF protein kinase 1

Therapy Area/IndicationsPancreatic NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmarkGermanySpain

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNeurosearch As

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesScandion Oncology As

Active IndicationsN/A

Inactive IndicationsPancreatic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A